JAK1 GOF
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Upadacitinib in Treatment of JAK/STAT Pathway Disorders With Activating Mutations (NCT07670156) | Lisa Satter | 2026-08-01 |
Track JAK1 GOF automatically
Every clearance here is in the API, with alerts when new ones post.